These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 15917309)
21. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880 [TBL] [Abstract][Full Text] [Related]
22. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Weldon CB; Elliott S; Zhu Y; Clayton JL; Curiel TJ; Jaffe BM; Burow ME Surgery; 2004 Aug; 136(2):346-54. PubMed ID: 15300201 [TBL] [Abstract][Full Text] [Related]
23. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?]. Rochefort H C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098 [TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618 [TBL] [Abstract][Full Text] [Related]
25. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832 [TBL] [Abstract][Full Text] [Related]
26. Identification of VDR-responsive gene signatures in breast cancer cells. Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416 [TBL] [Abstract][Full Text] [Related]
27. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990 [TBL] [Abstract][Full Text] [Related]
28. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer. Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304 [TBL] [Abstract][Full Text] [Related]
29. Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Geeraerts T; Deiva K; M'sika I; Salim H; Héry C; Tardieu M Neurosci Lett; 2006 May; 399(1-2):115-20. PubMed ID: 16481105 [TBL] [Abstract][Full Text] [Related]
30. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206 [TBL] [Abstract][Full Text] [Related]
31. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791 [TBL] [Abstract][Full Text] [Related]
32. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493 [TBL] [Abstract][Full Text] [Related]
33. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]. Zhang C; Cui GH; Liu F; Wu QL; Chen Y Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309 [TBL] [Abstract][Full Text] [Related]
34. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Hall JM; Korach KS Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845 [TBL] [Abstract][Full Text] [Related]
35. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532 [TBL] [Abstract][Full Text] [Related]
36. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. Chan CM; Lykkesfeldt AE; Parker MG; Dowsett M Clin Cancer Res; 1999 Nov; 5(11):3460-7. PubMed ID: 10589759 [TBL] [Abstract][Full Text] [Related]
37. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483 [TBL] [Abstract][Full Text] [Related]
38. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB. Maroni P; Bendinelli P; Matteucci E; Desiderio MA Carcinogenesis; 2007 Feb; 28(2):267-79. PubMed ID: 16840440 [TBL] [Abstract][Full Text] [Related]
39. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Porcile C; Bajetto A; Barbero S; Pirani P; Schettini G Ann N Y Acad Sci; 2004 Dec; 1030():162-9. PubMed ID: 15659794 [TBL] [Abstract][Full Text] [Related]